chenodeoxycholic acid has been researched along with alisol b monoacetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, PP; Feng, L; Huo, XK; Luan, ZL; Lv, X; Ma, XC; Ning, J; Sun, CP; Tian, XG; Wang, C; Zhang, BJ | 1 |
| Duan, XP; Huo, XK; Liu, KX; Liu, ZH; Meng, Q; Peng, JY; Sun, HJ; Sun, PY; Wang, CY | 1 |
2 other study(ies) available for chenodeoxycholic acid and alisol b monoacetate
| Article | Year |
|---|---|
Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism.
Topics: Alisma; Biological Products; Cells, Cultured; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Mutagenesis, Site-Directed; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Terpenes | 2019 |
Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
Topics: Animals; Chenodeoxycholic Acid; Cholestenones; Choline Deficiency; Dose-Response Relationship, Drug; Fibrosis; Gene Expression; Hepatocytes; Lipid Metabolism; Lipogenesis; Liver; Male; Methionine; Mice; Non-alcoholic Fatty Liver Disease; Pregnenediones; Primary Cell Culture; Protective Agents; Receptors, Cytoplasmic and Nuclear | 2017 |